Scientific paper - Original scientific paper
Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users
European addiction research, 24 (2018), 4; 189-200. urn:nbn:hr:184:728216

Roviš, Darko; Černelič Bizjak, Maša; Vasiljev Marchesi, Vanja; Petelin, Ana; Jenuš, Tina; Vidic, Suzana; Drevenšek, Gorazd; Jenko Pražnikar, Zala

Cite this document

Roviš, D., Černelič Bizjak, M., Vasiljev Marchesi, V., Petelin, A., Jenuš, T., Vidic, S. ... Jenko Pražnikar, Z. (2018). Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users. European addiction research, 24. (4), 189-200. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:728216

Roviš, Darko, et al. "Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users." European addiction research, vol. 24, no. 4, 2018, pp. 189-200. https://urn.nsk.hr/urn:nbn:hr:184:728216

Roviš, Darko, Maša Černelič Bizjak, Vanja Vasiljev Marchesi, Ana Petelin, Tina Jenuš, Suzana Vidic, Gorazd Drevenšek and Zala Jenko Pražnikar. "Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users." European addiction research 24, no. 4 (2018): 189-200. https://urn.nsk.hr/urn:nbn:hr:184:728216

Roviš, D., et al. (2018) 'Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users', European addiction research, 24(4), pp. 189-200. Available at: https://urn.nsk.hr/urn:nbn:hr:184:728216 (Accessed 25 June 2022)

Roviš D, Černelič Bizjak M, Vasiljev Marchesi V, Petelin A, Jenuš T, Vidic S, and sur.. Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users. European addiction research [Internet]. 2018 [cited 2022 June 25];24(4):189-200. Available at: https://urn.nsk.hr/urn:nbn:hr:184:728216

D. Roviš, et al., "Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users", European addiction research, vol. 24, no. 4, pp. 189-200, 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:728216. [Accessed: 25 June 2022]

Please login to the repository to save this object to your list.